These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10525118)

  • 21. Neurofurans, novel indices of oxidant stress derived from docosahexaenoic acid.
    Song WL; Lawson JA; Reilly D; Rokach J; Chang CT; Giasson B; FitzGerald GA
    J Biol Chem; 2008 Jan; 283(1):6-16. PubMed ID: 17921521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The isoprostanes. Current knowledge and directions for future research.
    Morrow JD; Roberts LJ
    Biochem Pharmacol; 1996 Jan; 51(1):1-9. PubMed ID: 8534261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of isoprostanes as markers of oxidative stress in neuronal tissue.
    Milatovic D; Aschner M
    Curr Protoc Toxicol; 2009 Feb; Chapter 12(Supplement 39):Unit12.14. PubMed ID: 20191108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IPF2alpha-I: an index of lipid peroxidation in humans.
    Praticò D; Barry OP; Lawson JA; Adiyaman M; Hwang SW; Khanapure SP; Iuliano L; Rokach J; FitzGerald GA
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3449-54. PubMed ID: 9520386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The isoprostanes: novel prostaglandin-like products of the free radical-catalyzed peroxidation of arachidonic acid.
    Liu T; Stern A; Roberts LJ; Morrow JD
    J Biomed Sci; 1999; 6(4):226-35. PubMed ID: 10420080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Derivatization of F2-isoprostanes with 1-pyrenyldiazomethane and their subsequent determination by fluorescence high-performance liquid chromatography.
    Ritov VB; Kelley DE; Kagan VE
    Anal Biochem; 2002 Dec; 311(1):10-8. PubMed ID: 12441147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of 8-epi-prostaglandin F(2alpha) in isolated rat kidney glomeruli by a radical-independent mechanism.
    Klein T; Neuhaus K; Reutter F; Nüsing RM
    Br J Pharmacol; 2001 Jul; 133(5):643-50. PubMed ID: 11429387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 8-iso-prostaglandin F2alpha as a useful clinical biomarker of oxidative stress in ESRD patients.
    Lim PS; Chang YM; Thien LM; Wang NP; Yang CC; Chen TT; Hsu WM
    Blood Purif; 2002; 20(6):537-42. PubMed ID: 12566669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid peroxidation, isoprostanes and vascular damage.
    Minuz P; Fava C; Lechi A
    Pharmacol Rep; 2006; 58 Suppl():57-68. PubMed ID: 17332673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel indices of oxidant stress in cardiovascular disease: specific analysis of F2-isoprostanes.
    Praticò D; Reilly M; Lawson JA; FitzGerald GA
    Agents Actions Suppl; 1997; 48():25-41. PubMed ID: 9177098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioimmunological measurement of F(2)-isoprostanes after hydrolysis of lipids in tissues.
    Södergren E; Vessby B; Basu S
    Prostaglandins Leukot Essent Fatty Acids; 2000 Sep; 63(3):149-52. PubMed ID: 10991772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin E supplementation decreases basal levels of F(2)-isoprostanes and prostaglandin f(2alpha) in rats.
    Södergren E; Cederberg J; Basu S; Vessby B
    J Nutr; 2000 Jan; 130(1):10-4. PubMed ID: 10613758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of oxygen tension on the generation of F2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes.
    Longmire AW; Swift LL; Roberts LJ; Awad JA; Burk RF; Morrow JD
    Biochem Pharmacol; 1994 Mar; 47(7):1173-7. PubMed ID: 8161346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. F2-isoprostanes as markers of oxidative stress in vivo: an overview.
    Milne GL; Musiek ES; Morrow JD
    Biomarkers; 2005 Nov; 10 Suppl 1():S10-23. PubMed ID: 16298907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications.
    Cracowski JL; Durand T; Bessard G
    Trends Pharmacol Sci; 2002 Aug; 23(8):360-6. PubMed ID: 12377577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isoprostanes: an overview and putative roles in pulmonary pathophysiology.
    Janssen LJ
    Am J Physiol Lung Cell Mol Physiol; 2001 Jun; 280(6):L1067-82. PubMed ID: 11350785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isoprostanes: generation, pharmacology, and roles in free-radical-mediated effects in the lung.
    Janssen LJ
    Pulm Pharmacol Ther; 2000; 13(4):149-55. PubMed ID: 10930353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioactive eicosanoids: role of prostaglandin F(2α) and F₂-isoprostanes in inflammation and oxidative stress related pathology.
    Basu S
    Mol Cells; 2010 Nov; 30(5):383-91. PubMed ID: 21113821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans.
    Morrow JD
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):279-86. PubMed ID: 15591226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry.
    Proudfoot J; Barden A; Mori TA; Burke V; Croft KD; Beilin LJ; Puddey IB
    Anal Biochem; 1999 Aug; 272(2):209-15. PubMed ID: 10415090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.